Clinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a review

Abstract Susceptibility-weighted imaging (SWI) is a technique that exploits the susceptibility difference between tissues to provide contrast for different regions of the brain. In essence, it uses the deoxygenated hemoglobin of veins, hemosiderin of hemorrhage, etc. as intrinsic contrast agents, allowing for much better visualization of blood and microvessels even without administration of an external contrast agent. It is a fast-evolving field that is being constantly improved and increasingly implemented with updates in relevant technology. Multiple studies have been done on the role of SWI in the management of various neurologic disorders and it is also being seen as a further step in the neuroradiologist’s goal of being able to noninvasively grade tumors in order to influence therapy. This article briefly reviews the evolution of SWI since its conception and provides the reader with a comprehensive summary of various studies that have been done on its application for detecting and grading intraaxial brain tumors, specifically gliomas. Other useful magnetic resonance techniques that have shown promise in grading gliomas are also discussed.

[1]  R. Mirimanoff,et al.  [A practical guide for the management of gliomas]. , 2007, Bulletin du cancer.

[2]  Jaladhar Neelavalli,et al.  Susceptibility‐weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses , 2006, Journal of magnetic resonance imaging : JMRI.

[3]  S Trattnig,et al.  High-Resolution Contrast-Enhanced, Susceptibility-Weighted MR Imaging at 3T in Patients with Brain Tumors: Correlation with Positron-Emission Tomography and Histopathologic Findings , 2007, American Journal of Neuroradiology.

[4]  P. Cassoni,et al.  Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation , 2009, La radiologia medica.

[5]  Paolo Ricci,et al.  Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies - how do they arise? , 2011, Environmental health : a global access science source.

[6]  R. Brasch,et al.  MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. , 2000, European journal of radiology.

[7]  L. Cui,et al.  Analysis of the mismatched manifestation between rCBF and rCBV maps in cerebral astrocytomas. , 2009, Clinical imaging.

[8]  J K Smith,et al.  Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.

[9]  Christopher P Hess,et al.  7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. , 2012, International journal of radiation oncology, biology, physics.

[10]  Daniela Prayer,et al.  Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T. , 2012, Magnetic resonance imaging.

[11]  K-H Chang,et al.  3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. , 2006, AJNR. American journal of neuroradiology.

[12]  D. Mikulis,et al.  Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. , 2011, AJR. American journal of roentgenology.

[13]  R I Grossman,et al.  Gliomas: correlation of magnetic susceptibility artifact with histologic grade. , 1997, Radiology.

[14]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[15]  Toshihiro Kumabe,et al.  Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. , 2006, Radiology.

[16]  D. Yousem,et al.  Detection of Intratumoral Calcification in Oligodendrogliomas by Susceptibility-Weighted MR Imaging , 2012, American Journal of Neuroradiology.

[17]  C. Matula,et al.  Fractal analysis of the susceptibility weighted imaging patterns in malignant brain tumors during antiangiogenic treatment: technical report on four cases serially imaged by 7 T magnetic resonance during a period of four weeks. , 2012, World neurosurgery.

[18]  H. Lanfermann,et al.  Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions , 2002, Neuroradiology.

[19]  Z. Wu,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.

[20]  C. Decaestecker,et al.  Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic Biopsies , 2008, American Journal of Neuroradiology.

[21]  S. Atlas,et al.  Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. , 1988, Radiology.

[22]  Bin Ai,et al.  Susceptibility-weighted imaging in grading brain astrocytomas. , 2010, European journal of radiology.

[23]  J. Raizer,et al.  Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study. , 2010, Radiology.

[24]  J. Waterton,et al.  Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas , 2012, International journal of cancer.

[25]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[26]  Bram Stieltjes,et al.  Biopsy Targeting Gliomas: Do Functional Imaging Techniques Identify Similar Target Areas? , 2010, Investigative radiology.

[27]  Jaladhar Neelavalli,et al.  Clinical applications of neuroimaging with susceptibility‐weighted imaging , 2005, Journal of magnetic resonance imaging : JMRI.

[28]  S. Ng,et al.  Differentiation of Pyogenic Brain Abscesses from Necrotic Glioblastomas with Use of Susceptibility-Weighted Imaging , 2012, American Journal of Neuroradiology.

[29]  J R Reichenbach,et al.  Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. , 1997, Radiology.

[30]  G. Jahng,et al.  Semiquantitative Assessment of Intratumoral Susceptibility Signals Using Non-Contrast-Enhanced High-Field High-Resolution Susceptibility-Weighted Imaging in Patients with Gliomas: Comparison with MR Perfusion Imaging , 2009, American Journal of Neuroradiology.

[31]  E. Haacke,et al.  Susceptibility-Weighted MR Imaging: A Review of Clinical Applications in Children , 2008, American Journal of Neuroradiology.

[32]  W. Lin,et al.  MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. , 1999, AJNR. American journal of neuroradiology.

[33]  J R Reichenbach,et al.  High-Resolution MR Venography at 3.0 Tesla , 2000, Journal of computer assisted tomography.

[34]  O. Abe,et al.  Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. , 2010, Magnetic resonance imaging.

[35]  Jan Sedlacik,et al.  Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma , 2010, Neuroradiology.

[36]  A. Bjørnerud,et al.  Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes , 2008, American Journal of Neuroradiology.

[37]  J. Debbins,et al.  Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma , 2012, American Journal of Neuroradiology.

[38]  S. Olmos,et al.  Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. , 2008, European journal of radiology.

[39]  S. Aoki,et al.  Precontrast and postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasms at 1.5 T , 2010, Japanese Journal of Radiology.

[40]  C. Matula,et al.  Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas , 2012, Neuroradiology.

[41]  Timothy P L Roberts,et al.  Neuro MR: Principles , 2007, Journal of magnetic resonance imaging : JMRI.

[42]  S. Trattnig,et al.  High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors , 2007, Neuroradiology.

[43]  P. Barker,et al.  Can Proton MR Spectroscopic and Perfusion Imaging Differentiate Between Neoplastic and Nonneoplastic Brain Lesions in Adults? , 2008, American Journal of Neuroradiology.

[44]  Sharmila Majumdar,et al.  GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T. , 2009, Magnetic resonance imaging.

[45]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.

[46]  T. Hirai,et al.  Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.

[47]  H. An,et al.  Improving high‐resolution MR bold venographic imaging using a T1 reducing contrast agent , 1999, Journal of magnetic resonance imaging : JMRI.

[48]  Markus Barth,et al.  Nonnvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[49]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[50]  G. Jahng,et al.  Added Value and Diagnostic Performance of Intratumoral Susceptibility Signals in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Preliminary Study , 2009, American Journal of Neuroradiology.

[51]  E. Melhem,et al.  Arterial Spin-Labeling and MR Spectroscopy in the Differentiation of Gliomas , 2007, American Journal of Neuroradiology.

[52]  X. Lou,et al.  Susceptibility-Weighted Imaging in the Diagnosis of Early Basal Ganglia Germinoma , 2009, American Journal of Neuroradiology.

[53]  Sandeep Bhuta,et al.  Susceptibility‐Weighted Imaging of the Brain: Current Utility and Potential Applications , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.